{"transactions":[{"id":827712,"issuer":{"id":4989,"kind":"organization","name":"GERON CORP"},"owners":[{"id":29182,"kind":"person","name":"Chinoporos Constantine","position":1,"cik":"0002014509","reported_name":"Chinoporos Constantine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-26T21:37:09.000Z","date":"2026-03-25","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in three equal annual installments starting on March 25, 2027, subject to the Reporting Person's continuous service (as defined in the Issuer's 2018 Equity Incentive Plan) with the Issuer through each such vesting date."}],"balance_after":270000,"derivative":{"exercise_price":1.57,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0002014509-26-000003","document":"form4-03262026_090305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/886744/000201450926000003/form4-03262026_090305.xml","form_type":"4"}},{"id":922276,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":29182,"kind":"person","name":"Chinoporos Constantine","position":1,"cik":"0002014509","reported_name":"Chinoporos Constantine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-04T00:03:25.000Z","date":"2026-02-03","kind":"other","planned":false,"acquired":false,"shares":57111,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-036176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2014509/000119312526036176/ownership.xml","form_type":"4"}},{"id":922275,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":29182,"kind":"person","name":"Chinoporos Constantine","position":1,"cik":"0002014509","reported_name":"Chinoporos Constantine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-04T00:03:25.000Z","date":"2026-02-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. (\"Purchaser\"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the \"Merger\"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the \"Closing Amount\") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration."}],"balance_after":57111,"source":{"system":"sec-edgar","filing":"0001193125-26-036176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2014509/000119312526036176/ownership.xml","form_type":"4"}},{"id":922274,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":29182,"kind":"person","name":"Chinoporos Constantine","position":1,"cik":"0002014509","reported_name":"Chinoporos Constantine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-04T00:03:25.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of compensatory Restricted Stock Units (\"RSUs\") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in full upon the earlier of (i) the consummation of a Change in Control (as defined in the Plan) or (ii) June 19, 2026, in each case, subject to the Reporting Person continuing to provide services through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total holdings have been adjusted to correct an administrative error in prior Form 4s that resulted in the overstatement of the total holdings."}],"balance_after":1057111,"source":{"system":"sec-edgar","filing":"0001193125-26-036176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014509/000119312526036176/ownership.xml","form_type":"4"}},{"id":1191103,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":29182,"kind":"person","name":"Chinoporos Constantine","position":1,"cik":"0002014509","reported_name":"Chinoporos Constantine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-27T00:14:55.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of compensatory Restricted Stock Units (\"RSUs\") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. One fourth (1/4th) of the compensatory RSUs shall vest on March 24, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory RSUs shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":621436,"source":{"system":"sec-edgar","filing":"0000950170-25-045609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014509/000095017025045609/ownership.xml","form_type":"4"}},{"id":1220038,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":29182,"kind":"person","name":"Chinoporos Constantine","position":1,"cik":"0002014509","reported_name":"Chinoporos Constantine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-07T01:30:11.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":447,"price":0.44,"value":196.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":271436,"source":{"system":"sec-edgar","filing":"0000950170-25-035040","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014509/000095017025035040/ownership.xml","form_type":"4"}},{"id":1278960,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":29182,"kind":"person","name":"Chinoporos Constantine","position":1,"cik":"0002014509","reported_name":"Chinoporos Constantine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-08T01:30:23.000Z","date":"2025-02-06","kind":"sale","planned":false,"acquired":false,"shares":28117,"price":0.61,"value":17151.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":271883,"source":{"system":"sec-edgar","filing":"0000950170-25-016585","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014509/000095017025016585/ownership.xml","form_type":"4"}},{"id":1572814,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":29182,"kind":"person","name":"Chinoporos Constantine","position":1,"cik":"0002014509","reported_name":"Chinoporos Constantine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-18T21:51:10.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the \"Plan\"). Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 28, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001096906-24-000489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014509/000109690624000489/form4.xml","form_type":"4"}}]}